Abstract
Although the effect of mood stabilizer valproic acid (VPA) through multiple signaling pathways has been shown, its therapeutic mechanism is still largely unknown. We investigated the effect of VPA (200 mg/kg, every 12 h) in sleep deprivation (SD) rats (72 h), the manic-like animal model, focusing on the N-methyl-d-aspartic acid (NMDA) receptor and signaling mediators of synaptic plasticity such as extracellular signal-regulated protein kinase (ERK), cAMP response element-binding protein (CREB), B cell chronic lymphocytic leukemia/lymphoma 2 (BCL2), and brain-derived neurotrophic factor (BDNF). SD reduced the expression of the NR2B subunit of the NMDA receptor in the frontal cortex and hippocampus but did not affect the expression of NR1 and NR2A subunits. In comparison, VPA inhibited the SD-induced reduction of NR2B expression in both brain regions. In addition, SD attenuated ERK phosphorylation in the frontal cortex and hippocampus, whereas VPA prevented the attenuation. VPA also protected the SD-induced decrease of CREB phosphorylation, BCL2 expression, and BDNF expression in the frontal cortex but not in the hippocampus. These results indicate that VPA could regulate NMDA receptor–ERK signaling in SD rats, preventing the SD-induced decrease of the expression of NR2B subunit and the activation of ERK signaling mediators such as ERK, CREB, BCL2, and BDNF.
This is a preview of subscription content, log in via an institution to check access.
References
Bazinet RP, Weis MT, Rapoport SI, Rosenberger TA (2006) Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder. Psychopharmacology (Berl) 184:122–129
Bowden CL, Karren NU (2006) Anticonvulsants in bipolar disorder. Aust NZ J Psychiatry 40:386–393
Chen G, Manji HK (2006) The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers. Curr Opin Psychiatry 19:313–323
Coenen AM, van Luijtelaar EL (1985) Stress induced by three procedures of deprivation of paradoxical sleep. Physiol Behav 35:501–504
Du J, Gray NA, Falke C, Yuan P, Szabo S, Manji HK (2003) Structurally dissimilar antimanic agents modulate synaptic plasticity by regulating AMPA glutamate receptor subunit GluR1 synaptic expression. Ann NY Acad Sci 1003:378–380
Einat H, Yuan P, Gould TD et al (2003) The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci 23:7311–7316
Fratta W, Collu M, Martellotta MC, Pichiri M, Muntoni F, Gessa GL (1987) Stress-induced insomnia: opioid–dopamine interactions. Eur J Pharmacol 3:437–440
Frau R, Orrù M, Puligheddu M et al (2008) Sleep deprivation disrupts prepulse inhibition of the startle reflex: reversal by antipsychotic drugs. Int J Neuropsychopharmacol 11:947–955
Frey BN, Valvassori SS, Réus GZ et al (2006) Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci 31:326–332
Gessa GL, Pani L, FrattaW SG (1995a) Depression and mania: from neurobiology to treatment. Raven, New York
Gessa GL, Pani L, Fadda P, Fratta W (1995b) Sleep deprivation in the rat: an animal model of mania. Eur Neuropsychopharmacol 5:S89–S93
Kanai H, Sawa A, Chen RW, Leeds P, Chuang DM (2004) Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons. Pharmacogenomics J 4:336–344
Kim MJ, Dunah AW, Wang YT, Sheng M (2005) Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras–ERK signaling and AMPA receptor trafficking. Neuron 46:745–760
Kim E, Grover LM, Bertolotti D, Green TL (2010) Growth hormone rescues hippocampal synaptic function after sleep deprivation. Am J Physiol Regul Integr Comp Physiol 298:1588–1596
Lan MJ, McLoughlin GA, Griffin JL et al (2009) Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder. Mol Psychiatry 14:269–279
Martin ED, Pozo MA (2004) Valproate reduced excitatory postsynaptic currents in hippocampal CA1 pyramidal neurons. Neuropharmacology 46:555–561
McDermott CM, Hardy MN, Bazan NG, Magee JC (2006) Sleep deprivation-induced alterations in excitatory synaptic transmission in the CA1 region of the rat hippocampus. J Physiol 570:553–565
Nasrallah HA, Ketter TA, Kalali AH (2006) Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature. J Affect Disord 95:69–78
Rao JS, Harry GJ, Rapoport SI, Kim HW (2010) Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry 15:384–392
Sanacora G, Zarate CA, Krystal JH, Manji HK (2008) Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov 7:426–437
Sweatt JD (2004) Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol 14:311–317
Yuan P, Zhou R, Wang Y et al (2010) Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia. J Affect Disord 124:164–169
Zeise ML, Kasparow S, Zieglgansberger W (1991) Valproate suppresses N-methyl-d-aspartate-evoked, transient depolarizations in the rat neocortex in vitro. Brain Res 544:345–348
Acknowledgments
This research was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2009–0073950).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, H.J., Kang, W.S., Paik, J.W. et al. Effect of Valproic Acid Through Regulation of NMDA Receptor–ERK Signaling in Sleep Deprivation Rats. J Mol Neurosci 47, 554–558 (2012). https://doi.org/10.1007/s12031-011-9673-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-011-9673-5